United States · FDA National Drug Code directory
Doxepin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-7819_51e41985-0be0-4965-8562-d1df183e2575
- Product NDC
- 50090-7819
- Form
- CAPSULE
- Composition / generic term
- Doxepin Hydrochloride
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220627
- Source listing expiry
- 20261231
Source-listed ingredients
- DOXEPIN HYDROCHLORIDE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (50090-7819-1) · 50090-7819-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →